Pilot Study of OMEGA-3 and Vitamin D in High-Dose in Type I Diabetic Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

July 23, 2018

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Diabetes Mellitus, Type 1HypoglycemiaDiabetes MellitusDiabetes, Autoimmune
Interventions
DRUG

Cholecalciferol

Oral Administration

DRUG

Omega 3 fatty acid

Oral Administration

Trial Locations (1)

33136

Diabetes Research Institute, University of Miami Miller School of Medicine, Miami

All Listed Sponsors
collaborator

Diabetes Research Institute Foundation

OTHER

lead

Rodolfo Alejandro

OTHER